Increased intraocular pressure and corneal endothelial cell loss following phacoemulsification surgery. 2004

Ryuzi Yachimori, and Toshie Matsuura, and Ken Hayashi, and Hideyuki Hayashi
Hayashi Eye Hospital, Fukuoka, Japan.

OBJECTIVE To compare the influence of low-molecular-weight viscoelastics on postoperative intraocular pressure (IOP) and corneal endothelial cell loss after phacoemulsification METHODS Sixty-nine eyes undergoing phacoemulsification surgery were randomized to have either Opegan (Santen Pharmaceuticals, Osaka, Japan) alone or the soft-shell technique using Viscoat (Alcon Surgical, Fort Worth, TX) during phacoemulsification. The IOP was measured preoperatively and at 5 and 24 hours postoperatively. Intraoperative factors and corneal endothelial cell loss were also examined. RESULTS Mean IOP was increased at 5 hours after surgery but returned to preoperative levels at 24 hours in the Opegan group, whereas it remained higher at 24 hours than at preoperative levels in the soft-shell group. When comparing groups, IOP at 5 and 24 hours postoperatively in the Opegan group was significantly less than that in the soft-shell group. Corneal endothelial cell loss was approximately the same in the two groups. CONCLUSIONS The increase in IOP following phacoemulsification surgery with the use of Opegan was less than that with the soft-shell technique using Viscoat, although endothelial injury was almost the same.

UI MeSH Term Description Entries
D007429 Intraocular Pressure The pressure of the fluids in the eye. Ocular Tension,Intraocular Pressures,Ocular Tensions,Pressure, Intraocular,Pressures, Intraocular,Tension, Ocular,Tensions, Ocular
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009798 Ocular Hypertension A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma. Glaucoma, Suspect,Hypertension, Ocular,Glaucomas, Suspect,Hypertensions, Ocular,Ocular Hypertensions,Suspect Glaucoma,Suspect Glaucomas
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002807 Chondroitin A mucopolysaccharide constituent of chondrin. (Grant & Hackh's Chemical Dictionary, 5th ed)
D002809 Chondroitin Sulfates Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; DERMATAN SULFATE) is a misnomer and this compound is not a true chondroitin sulfate. Chondroitin 4-Sulfate,Chondroitin 6-Sulfate,Chondroitin Sulfate A,Chondroitin Sulfate C,Blutal,Chondroitin 4-Sulfate, Aluminum Salt,Chondroitin 4-Sulfate, Potassium Salt,Chondroitin 6-Sulfate, Potassium Salt,Chondroitin 6-Sulfate, Sodium Salt,Chondroitin Sulfate,Chondroitin Sulfate 4-Sulfate, Sodium Salt,Chondroitin Sulfate, Calcium Salt,Chondroitin Sulfate, Iron (+3) Salt,Chondroitin Sulfate, Iron Salt,Chondroitin Sulfate, Potassium Salt,Chondroitin Sulfate, Sodium Salt,Chondroitin Sulfate, Zinc Salt,Chonsurid,Sodium Chondroitin Sulfate,Translagen,Chondroitin 4 Sulfate,Chondroitin 4 Sulfate, Aluminum Salt,Chondroitin 4 Sulfate, Potassium Salt,Chondroitin 6 Sulfate,Chondroitin 6 Sulfate, Potassium Salt,Chondroitin 6 Sulfate, Sodium Salt,Chondroitin Sulfate 4 Sulfate, Sodium Salt,Chondroitin Sulfate, Sodium,Sulfate, Chondroitin,Sulfate, Sodium Chondroitin,Sulfates, Chondroitin
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug

Related Publications

Ryuzi Yachimori, and Toshie Matsuura, and Ken Hayashi, and Hideyuki Hayashi
January 1996, Journal of cataract and refractive surgery,
Ryuzi Yachimori, and Toshie Matsuura, and Ken Hayashi, and Hideyuki Hayashi
February 2024, International ophthalmology,
Ryuzi Yachimori, and Toshie Matsuura, and Ken Hayashi, and Hideyuki Hayashi
January 1993, Refractive & corneal surgery,
Ryuzi Yachimori, and Toshie Matsuura, and Ken Hayashi, and Hideyuki Hayashi
August 1994, Ophthalmic surgery,
Ryuzi Yachimori, and Toshie Matsuura, and Ken Hayashi, and Hideyuki Hayashi
May 1985, Ophthalmology,
Ryuzi Yachimori, and Toshie Matsuura, and Ken Hayashi, and Hideyuki Hayashi
December 2005, American journal of ophthalmology,
Ryuzi Yachimori, and Toshie Matsuura, and Ken Hayashi, and Hideyuki Hayashi
June 2005, American journal of ophthalmology,
Ryuzi Yachimori, and Toshie Matsuura, and Ken Hayashi, and Hideyuki Hayashi
January 2019, Beyoglu eye journal,
Ryuzi Yachimori, and Toshie Matsuura, and Ken Hayashi, and Hideyuki Hayashi
January 1996, Journal of cataract and refractive surgery,
Ryuzi Yachimori, and Toshie Matsuura, and Ken Hayashi, and Hideyuki Hayashi
January 2014, Klinika oczna,
Copied contents to your clipboard!